Advertisement

Psychopharmacology

, Volume 236, Issue 2, pp 809–809 | Cite as

Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

  • Adam L. HalberstadtEmail author
  • Landon M. Klein
  • Muhammad Chatha
  • Laura B. Valenzuela
  • Alexander Stratford
  • Jason Wallach
  • David E. Nichols
  • Simon D. Brandt
Correction
  • 283 Downloads

Correction to: Psychopharmacology

  https://doi.org/10.1007/s00213-018-5055-9

The author of this article wanted to change the Acknowledgments section to:

These studies were supported by an award from NIDA (R01 DA041336), as well as by the Veteran’s Administration VISN 22 Mental Illness Research, Education, and Clinical Center. Receptor binding and functional data were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program (NIMH PDSP), Contract No. HHSN-271-2008-00025-C. The NIMH PDSP is directed by Dr. Bryan Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, USA.

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Adam L. Halberstadt
    • 1
    • 2
    Email author
  • Landon M. Klein
    • 1
  • Muhammad Chatha
    • 1
  • Laura B. Valenzuela
    • 1
  • Alexander Stratford
    • 3
  • Jason Wallach
    • 4
  • David E. Nichols
    • 5
  • Simon D. Brandt
    • 6
  1. 1.Department of PsychiatryUniversity of California San DiegoLa JollaUSA
  2. 2.Research ServiceVA San Diego Healthcare SystemSan DiegoUSA
  3. 3.Synex Synthetics BVMaastrichtThe Netherlands
  4. 4.Department of Pharmaceutical Sciences, Philadelphia College of PharmacyUniversity of the SciencesPhiladelphiaUSA
  5. 5.Division of Chemical Biology and Medicinal ChemistryUniversity of North CarolinaChapel HillUSA
  6. 6.School of Pharmacy and Biomolecular SciencesLiverpool John Moores UniversityLiverpoolUK

Personalised recommendations